drugset / Trial / NCT07465965

A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults

NCT07465965

Phase 1 Recruiting 60 enrolled Shanghai World Leader Pharmaceutical Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The specific aim of this study is to examine the Safety, Tolerability and Pharmacokinetic of Semaglutide Nasal Spray compared with placebo and positive control in Adult Overweight or Obese Participants.

Timeline

Start
2026-03-02
Primary completion
2026-08-21
Completion
2026-08-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Semaglutide Peptide Intranasal
Comparator Semaglutide Peptide

Indications